CClinicalTrials.gg
CompletedNCT04997707NIOMUpdated Aug 10, 2021

The Effect of Balanced Anesthesia Regimen on Intraoperative Trans-cranial Motor Evoked Potential During Spine Surgeries:

A Phase 4 interventional study of Propofol Abbott and Sevoflurane Inhalation Solution in Motor Evoked Potential, sponsored by El-Sahel Teaching Hospital. Completed at 2 sites in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-08-10.

Sponsored by El-Sahel Teaching Hospital · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Registered 4 years 3 months after the study started (first participant enrolled Apr 2017, registered Jul 2021).
Phase
Phase 4
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

transcranial motor evoked potentials (TcMEP) were proved to be useful during complicated spinal surgeries to prevent iatrogenic complications. The effect of anesthetic agents was comprehensively discussed in literature. The Investigators studied a new balanced anesthetic protocol using propofol and sevoflurane in addition to continuous fentanyl infusion in which they compared values and ratios of amplitudes and latencies of TcMEP waves at different time point.

Read the detailed description

This is a prospective double- blind randomized controlled study. After approval by the ethics committee at the National Cancer Institute (Cairo University) and El-Sahel Teaching Hospital (GOHTI, Cairo) and after written informed consents,46 ASA I-II patients who are scheduled for various spinal surgeries (such as: intra-spinal tumor resection, spondylolisthesis correction, traumatic spinal fractures' fixation,...) will be included in this study. Surgeons and neurophysiologists will be the same and will be blind to the anesthetic techniques in all patients.

Randomization list will be generated then patients will be randomized into two groups: control and study group.

Preoperatively, all patients will be checked for any exclusion criteria and the routine preoperative evaluation will be done. On arriving operative theater, all patients will receive 0.1 mg/kg midazolam IV. After connecting all the basic monitors' cables (NIBP, pulse oximetry and ECG) and canulating the radial artery to monitor IBP, induction of anesthesia will be done to all patients with 4μg/kg fentanyl, 2-3mg/kg propofol IV and 0.5mg/kg atracurium to facilitate endotracheal intubation. After intubation, central venous catheter( CVP), temperature probe through nasopharynx and urinary catheter will be inserted. Fentanyl infusion will be maintained in a rate of 2μg/kg/hour and will be discontinued 60 minutes before recovery.

From this time on, patients will be randomly allocated into control and study groups, each group is 30 patients; control group is the propofol (P) group and the study group is the balanced anesthesia (BA) group.

Control Group: propofol will be infused continuously in a rate of 75-100 μg/kg/min Study Group: propofol infusion in a rate of 25μg/kg/min will be given with sevoflurane. Sevoflurane concentration will be individually calculated by age-adjusted end - tidal MAC as follows: for age of 18-25 years, 26-40 years and ≥40 years MAC will be 2.6%, 2.2% and 1.8% respectively then final concentration to be delivered will be 0.2% lower than calculated half MAC.

Patients will be mechanically ventilated with O2/Air mixture (FiO2 50%) in a rate of 10-12/minute and tidal volume of 6-8 ml/kg to insure oxygen saturation (SpO2) around 99% and end-tidal CO2 between 28-35 mmHg. Body temperature must be kept between 35-37oC( Celsius degrees) using warm fluids and warming blankets.

Intraoperative fluids will be given guided by central venous pressure (CVP)and urine output.

Hypotension ( mean arterial blood pressure (MAP) ˂60 mmHg in normotensive patients or ˂70 mmHg in hypertensive patients) will be treated with Norepinephrine (Levophed®) in an infusion of 0.05-1.0μg /kg/min.

TcMEP Monitoring:

After induction, transcranial stimulation electrode will be connected at C1- C2, Cz and C3-C4 (10-10 international system) and subdermal needles inserted in the appropriate muscles, according to the scenario selected, processing will be done using NIM-SPINE™ SYSTEM (2005 Medtronic Sofamor Danek USA, Inc.). The stimulation used is a train-of-five square wave stimulation, 2ms inter-stimulus interval, 500 μs width and 40-220 mA intensity which can be increased with 10 mA steps till muscle answer potential is recorded.

The first TcMEP (R1) will be taken before positioning and surgical incision, at least 20-25 minutes after induction; fading of the neuromuscular blockade will be checked by train-of-four (TOF) and double- burst stimulation using peripheral nerve stimulator connected to the ulnar nerve.

A second reading (R2), which is the surgical baseline reading, will be taken 20 minutes later; during which positioning of the patient is done; again muscle relaxant fading is confirmed before the reading as above. A third reading (R3) will be taken after the surgical incision.

With every TcMEP reading, MAP, pulse rate, Oximetry, En-tidal CO2, nasopharyngeal temperature, ulnar train-of-four response, sevoflurane percentage concentration / propofol infusion rate and CVP will be recorded.

Comparison between R1 and R2 will be dedicated to the effect of anesthetic regimen, while subsequent readings will indicate both the effect of anesthetic regimen and any surgical insult (if any).

Decrease in every wave amplitude by more than 50% in relation to R1 and increase in latency more than 2 ms will be recorded as an alarming criterion.

On recovery:

After fulfilling the Modified Aldrete Recovery Score, patients will be discharged from postoperative recovery unit (PACU) to the intermediate care unit. All patients with an alarming criterion will be checked by neurosurgeon for any motor deficit.

Sample size estimation:

The aim of this study is to compare the effects of balanced anesthesia using low dose propofol and less than half MAC sevoflurane versus propofol based anesthesia while using medium-dose fentanyl in both techniques on TcMEP intraoperative monitoring during spine surgeries. Based on the previous paper published by Palazon et al., 2015, the difference in latency between the 2 groups was 3 with an average variability of 3. A total sample size of 46 (23 per group) will be sufficient to detect that effect size, with power 90% and 5% significance level the sample size was calculated by the G power program.

02

Conditions studied

  • Motor Evoked Potential

Keywords

  • motor-evoked potentials, sevoflurane, balanced anesthesia,
03

In context

Lead sponsor

El-Sahel Teaching Hospital is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • (ASA) grades I-II who were scheduled for spinal surgeries (intraspinal tumors resection, spondylolisthesis correction, traumatic spinal fractures fixation....etc)

Exclusion criteria

Exclusion Criteria:

  • Patients aged less than 18 years, or with history of drug abuse, any pulmonary disease, preoperative motor deficit, history of epilepsy, pacemakers and cochlear implants, previous intracranial surgeries or needed to deepen anesthetic plane during surgery
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    P group

    75-100 µg/kg/min propofol

    Drug: Propofol Abbott · Diagnostic Test: transcranial motor evoked potential(Tcm

  • Active comparator
    BA group

    25ug/kg/min propofol and 0.2% below corrected-to-age- half MAC of sevoflurane

    Drug: Propofol Abbott · Drug: Sevoflurane Inhalation Solution · Diagnostic Test: transcranial motor evoked potential(Tcm

Interventions

  • DrugPropofol Abbott

    in a rate of 75-100 μg/kg/min in P group, and 25μg/kg/min in BA group

    Also known as: propofol

  • DrugSevoflurane Inhalation Solution

    in BA group will be calculated by age-adjusted end - tidal MAC as follows: for age of 18-25 years, 26-40 years and ≥40 years MAC will be 2.6%, 2.2% and 1.8% respectively then final concentration to be delivered will be 0.2% lower than calculated half MAC.

    Also known as: sevoflurane

  • Diagnostic testtranscranial motor evoked potential(Tcm

    using NIM-SPINE™ SYSTEM (2005 Medtronic Sofamor Danek USA, Inc.). The stimulation used is a train-of-five square wave stimulation, 2ms inter-stimulus interval, 500 μs width and 40-220 mA intensity which can be increased with 10 mA steps till muscle answer potential is recorded.

    Also known as: intraoperative neurophysiological monitoring (IONM)

06

What researchers measure

Primary outcomes

  1. TcMEP Monitoring (R1)

    The first TcMEP (R1) was taken before positioning and surgical incision, at least 20-25 min

    Time frame: " up to 45 minutes"

  2. TcMEP Monitoring(R2)

    R2), after positioning of the patient

    Time frame: "up to 60 minutes"

  3. TcMEP Monitoring(R3)

    (R3) was taken after the surgical incision

    Time frame: " up to 75 minutes"

Secondary outcomes

  1. Mean arterial blood pressure (MAP)

    in mmHg

    Time frame: " up to 5 hours"

  2. pulse rate

    number / minute

    Time frame: " up to 5 hours"

  3. Spo2

    in percentage

    Time frame: " up to 5 hours"

  4. temperature

    in C

    Time frame: " up to 5 hours"

  5. propofol infusion rate

    ml/hour

    Time frame: " up to 5 hours"

  6. end-tidal sevoflurane

    percentage

    Time frame: " up to 5 hours"

  7. Central venous pressure (CVP)

    cmH2O

    Time frame: " up to 5 hours"

  8. end-tidal CO2

    mmHg

    Time frame: " up to 5 hours"

  9. PaO2

    mmHg

    Time frame: " up to 5 hours"

  10. PaCo2

    mmHg

    Time frame: " up to 5 hours"

  11. PHa

    Number

    Time frame: " up to 5 hours"

  12. Train-of-four stimulation ( TOF)

    percentage

    Time frame: " up to 5 hours"

  13. R3/R2 ratio

    percentage

    Time frame: " up to 5 hours"

07

Study locations

2 sites
  • National cancer Institute
    Cairo, 000000, Egypt
  • El sahel Teaching Hospital
    Cairo, 767565, Egypt
08

References and documents

Individual participant data

Plan to share: No — Methods and results

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 10, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04997707
Lead sponsor
El-Sahel Teaching Hospital
Responsible party
Samir Ahmed Ahmed ElKafrawy (consultant of anesthesia, head of neuroanesthesia unit, El-Sahel Teaching Hospital) — Principal investigator
First posted
Aug 10, 2021
Start date
Apr 6, 2017
Primary completion
Mar 5, 2020
Completion
Apr 5, 2021
Last update
Aug 10, 2021

Study contacts

Samir A El kafrawy, MD
principal investigator · El-Sahel Teaching Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion